Patent ID: 8841129

Claim:
A method of monitoring inhibition of platelet function response comprising: collecting less than 100 μl of platelet-containing mammalian test blood from a patient treated with a platelet inhibitor; mixing the test blood with a platelet agonist to generate agonist-activated test blood; monitoring an extracellular platelet-release-reaction light emission in the agonist-activated test blood to generate a test measurement of the light emission; comparing the measured test light emission to a standard value, wherein the standard value of the light emission is determined by collecting platelet-containing standard blood from the patient; mixing the standard blood with the platelet agonist to generate agonist-activated standard blood; and monitoring an extracellular platelet-release-reaction light emission in the agonist-activated standard blood to generate the standard value, wherein the standard blood is collected from the patient before the patient is treated with the platelet inhibitor; and determining an inhibitory effect of platelet activation based on the comparison of the measured test light emission to the standard value.